Hematology/Oncology Education and CME

My Education
Keep track of all your educational activities here
  • Access activities already in progress
  • See credits earned to date
  • Print certificates
  • Top Picks
    • Video Perspectives: Bladder Cancer
    • Multiple Myeloma Awareness
    • Diagnostic and Therapeutic Challenges in Von Willebrand Disease
    • Mechanism of Action Video: Facing the challenges of ER+ mBC

Select a Topic

  • FILTER BY:
Video Perspectives Bladder Cancer

Video perspectives include topics such as findings of the Checkmate studies, the emerging field of immunotherapy, the natural history of bladder cancer, intravesical and…

go to activity»
Multiple Myeloma Awareness

In recognition of Multiple Myeloma Awareness Month, Healio Education Lab interviewed Kenneth Anderson, MD to find out what the future may hold for patients with the…

go to activity»
Mechanism of Action Video: Facing the challenges of ER+ mBC

Many breast cancers have estrogen receptors, and the growth of these tumors..….

go to activity»
Hot Topics in Metastatic Breast Cancer Management: Clinical Advances with CDK4/6 Inhibitors
CME

Hot Topics in Metastatic Breast Cancer Management: Clinical Advances with CDK4/6 Inhibitors

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

Expiration Date: 1/19/2018
Credit Type(s): CME | Credit: 1

While the mortality rates for advanced or metastatic breast cancer (MBC) have steadily decreased, in part due to improved treatment options, the 5-year survival rate for…

go to activity»
Head and Neck Cancers

Video perspectives include topics such as the link between HPV infection and head and neck cancer, patient education, and developments that have resulted from…

go to activity»
Toward Precision Medicine for Advanced Melanoma Management: Making the Most of Targeted Agents
CME

Toward Precision Medicine for Advanced Melanoma Management: Making the Most of Targeted Agents

This activity is supported by an educational grant from Novartis.

Expiration Date: 1/25/2018
Credit Type(s): CME | Credit: 1

The identification and utilization of melanoma specific biomarkers continues to be of importance for diagnosis and prognosis, and the selection of tailored therapy…

go to activity»
The Identification and Management of Immune-related Adverse Events in Patients with Cancer: Practice Essentials for Emergency Medicine Providers
CMECNE

The Identification and Management of Immune-related Adverse Events in Patients with Cancer: Practice Essentials for Emergency Medicine Providers

This activity is supported by an educational grant from Bristol-Myers Squibb.

Expiration Date: 3/20/2018
Credit Type(s): CNE / CME | Credit: 1

The incorporation of immunotherapies, especially the immune checkpoint inhibitors, into treatment regimens for patients with cancer, have significantly improved clinical…

go to activity»
activity image
CME

Diagnostic and Therapeutic Challenges in Von Willebrand Disease

This activity is supported by an educational grant from Shire.

Expiration Date: 2/2/2018
Credit Type(s): CME | Credit: 1.5

With the significant variability in the subtypes and clinical manifestations of von Willebrand disease (VWD), diagnosis and treatment of affected individuals are often…

go to activity»
Combination Strategies in Melanoma Management: What’s New and What’s Next
CME

Combination Strategies in Melanoma Management: What’s New and What’s Next

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 1/24/2018
Credit Type(s): CME | Credit: 0.75

Melanoma is the sixth most common cancer in the United States and the deadliest form of skin cancer. Although it is often curable if caught early, treatment options are…

go to activity»
MPN Updates

MPN Updates

This electronic newsletter is sponsored by Incyte Corp. through a third-party independent grant.

December 13, 2016

As the standards of care for patients with myeloproliferative neoplasms (MPNs) continue to evolve, physicians must stay informed on current research and treatment…

go to activity»
Breakthroughs in the Treatment of Bladder Cancer
CME

Breakthroughs in the Treatment of Bladder Cancer

This activity is supported by an educational grant from Bristol-Myers Squibb.

Expiration Date: 12/13/2017
Credit Type(s): CME | Credit: 0.5

Assessment of immune checkpoint blockade inhibitors in the treatment of bladder cancer have demonstrated significant enhancements to clinical outcomes. With multiple…

go to activity»
Immune Checkpoint Inhibition for Melanoma Management: When, What, How, and in Whom?
CME

Immune Checkpoint Inhibition for Melanoma Management: When, What, How, and in Whom?

This activity is supported by educational grants from Bristol-Myers Squibb and Merck & Co., Inc.

Expiration Date: 1/24/2018
Credit Type(s): CME | Credit: 1

It is estimated that 76,380 new cases of melanoma will be diagnosed in the United Stated in 2017, with approximately 10,130 disease-related deaths. Recent advances in…

go to activity»
Video Perspectives Bladder Cancer

Video perspectives include topics such as findings of the Checkmate studies, the emerging field of immunotherapy, the natural history of bladder cancer, intravesical and…

go to activity»
The Identification and Management of Immune-related Adverse Events in Patients with Cancer: Practice Essentials for Emergency Medicine Providers
CMECNE

The Identification and Management of Immune-related Adverse Events in Patients with Cancer: Practice Essentials for Emergency Medicine Providers

This activity is supported by an educational grant from Bristol-Myers Squibb.

Expiration Date: 3/20/2018
Credit Type(s): CNE / CME | Credit: 1

The incorporation of immunotherapies, especially the immune checkpoint inhibitors, into treatment regimens for patients with cancer, have significantly improved clinical…

go to activity»
Multiple Myeloma Awareness

In recognition of Multiple Myeloma Awareness Month, Healio Education Lab interviewed Kenneth Anderson, MD to find out what the future may hold for patients with the…

go to activity»
activity image
CME

Diagnostic and Therapeutic Challenges in Von Willebrand Disease

This activity is supported by an educational grant from Shire.

Expiration Date: 2/2/2018
Credit Type(s): CME | Credit: 1.5

With the significant variability in the subtypes and clinical manifestations of von Willebrand disease (VWD), diagnosis and treatment of affected individuals are often…

go to activity»
Mechanism of Action Video: Facing the challenges of ER+ mBC

Many breast cancers have estrogen receptors, and the growth of these tumors..….

go to activity»
Combination Strategies in Melanoma Management: What’s New and What’s Next
CME

Combination Strategies in Melanoma Management: What’s New and What’s Next

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 1/24/2018
Credit Type(s): CME | Credit: 0.75

Melanoma is the sixth most common cancer in the United States and the deadliest form of skin cancer. Although it is often curable if caught early, treatment options are…

go to activity»
Hot Topics in Metastatic Breast Cancer Management: Clinical Advances with CDK4/6 Inhibitors
CME

Hot Topics in Metastatic Breast Cancer Management: Clinical Advances with CDK4/6 Inhibitors

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

Expiration Date: 1/19/2018
Credit Type(s): CME | Credit: 1

While the mortality rates for advanced or metastatic breast cancer (MBC) have steadily decreased, in part due to improved treatment options, the 5-year survival rate for…

go to activity»
MPN Updates

MPN Updates

This electronic newsletter is sponsored by Incyte Corp. through a third-party independent grant.

December 13, 2016

As the standards of care for patients with myeloproliferative neoplasms (MPNs) continue to evolve, physicians must stay informed on current research and treatment…

go to activity»
Head and Neck Cancers

Video perspectives include topics such as the link between HPV infection and head and neck cancer, patient education, and developments that have resulted from…

go to activity»
Breakthroughs in the Treatment of Bladder Cancer
CME

Breakthroughs in the Treatment of Bladder Cancer

This activity is supported by an educational grant from Bristol-Myers Squibb.

Expiration Date: 12/13/2017
Credit Type(s): CME | Credit: 0.5

Assessment of immune checkpoint blockade inhibitors in the treatment of bladder cancer have demonstrated significant enhancements to clinical outcomes. With multiple…

go to activity»
Toward Precision Medicine for Advanced Melanoma Management: Making the Most of Targeted Agents
CME

Toward Precision Medicine for Advanced Melanoma Management: Making the Most of Targeted Agents

This activity is supported by an educational grant from Novartis.

Expiration Date: 1/25/2018
Credit Type(s): CME | Credit: 1

The identification and utilization of melanoma specific biomarkers continues to be of importance for diagnosis and prognosis, and the selection of tailored therapy…

go to activity»
Immune Checkpoint Inhibition for Melanoma Management: When, What, How, and in Whom?
CME

Immune Checkpoint Inhibition for Melanoma Management: When, What, How, and in Whom?

This activity is supported by educational grants from Bristol-Myers Squibb and Merck & Co., Inc.

Expiration Date: 1/24/2018
Credit Type(s): CME | Credit: 1

It is estimated that 76,380 new cases of melanoma will be diagnosed in the United Stated in 2017, with approximately 10,130 disease-related deaths. Recent advances in…

go to activity»
In My Setting: Myeloproliferative Neoplasms

Three key opinion leaders share their thoughts on what is developing in the area of myeloproliferative neoplasms….

go to activity»
ims lung cancer

In My Setting: Lung Cancer

September 15, 2016

Catch up with three clinicians as they provide insightful information on the topic of lung cancer….

go to activity»
Immuno-oncology Forum: Focus on Non-small Cell Lung Cancer
CME

Immuno-Oncology Forum: Focus on Non-Small Cell Lung Cancer

This activity is supported by educational grants from Bristol-Myers Squibb; Genentech, Inc.; and Merck & Co., Inc.

Expiration Date: 10/2/2017
Credit Type(s): CME | Credit: 1.5

Lung cancer accounts for 27% of all cancer deaths in the United States, making it the leading cause of cancer mortality. Despite therapeutic advances in the last two…

go to activity»
Individualized Prophylaxis in Hemophilia
CMECNECPE

Individualized Prophylaxis in Hemophilia

Support for this activity has been made possible through an educational grant from Bayer HealthCare Pharmaceuticals

Expiration Date: 9/9/2017
Credit Type(s): CME / CNE / CPE | Credit: 1

This program will provide education for hematologists, nurses, pharmacists, and other healthcare providers involved in hemophilia care on how to better determine…

go to activity»
Video perspectives lung cancer

Video perspectives include topics such as the epidemiology of lung cancer and how it contributes to the clinical challenges oncologists face in the field of precision…

go to activity»
Targeting B-Cell Lymphomas: The Latest Updates in Therapies, Practice Strategies, and Clinical Research
CME

Targeting B-Cell Lymphomas: The Latest Updates in Therapies, Practice Strategies, and Clinical Research

This activity is supported by independent educational grants from Pharmacyclics, Inc. and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC., and Infinity Pharmaceuticals, Inc.

July 16, 2016

The standards of care in treatment for non-Hodgkin lymphomas (NHL) are evolving as new therapies receive FDA approval and new evidence provides insight into optimal…

go to activity»
Management of Multiple Myeloma: Using Emerging Therapies with ASCT
CME

Management of Multiple Myeloma: Using Emerging Therapies with ASCT

This activity is supported by educational grants from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Spectrum Pharmaceuticals, Inc.; and Takeda Oncology.

Expiration Date: 6/1/2017
Credit Type(s): CME | Credit: 1

Multiple myeloma management has undergone profound changes in the past few decades, this is largely due to advances in understanding the disease biology and the…

go to activity»
In My Setting: Sarcoma

Read what three clinicians have to say about the current state of sarcoma treatment options….

go to activity»
Are you ready to take the cholangioscopy visualization challenge?

Cholangioscopy Visualization Challenge

This activity is sponsored by Boston Scientific.

January 3, 2017

How familiar are you with the various disease states found throughout the biliary and pancreatic ducts using digital cholangioscopy?..….

go to activity»